BRIEF-Pyxis Oncology Announces Up To $114 Million Private Placement Financing To Advance Micvo Through Key Clinical Milestones

Pyxis Oncology, Inc.

Pyxis Oncology, Inc.

PYXS

0.00

June 30 (Reuters) - Pyxis Oncology Inc PYXS.O:

  • PYXIS ONCOLOGY ANNOUNCES UP TO $114 MILLION PRIVATE PLACEMENT FINANCING TO ADVANCE MICVO THROUGH KEY CLINICAL MILESTONES

  • PYXIS ONCOLOGY - UPFRONT PROCEEDS EXPECTED TO EXTEND CASH RUNWAY INTO Q2 2027

  • PYXIS ONCOLOGY - SELLS 19.6 MILLION SHARES AT $2.55 EACH WITH WARRANTS AT $3.29 EXERCISE PRICE

  • PYXIS ONCOLOGY: FINANCING LED BY BVF PARTNERS L.P. WITH PARTICIPATION FROM GORDONMD GLOBAL INVESTMENTS, RTW INVESTMENTS, COASTLANDS CAPITAL

  • PYXIS ONCOLOGY - EXPECTS UPDATED PHASE 1 MONOTHERAPY DATA IN FALL 2026 AND PHASE 1/2 DATA IN Q4 2026

Source text: ID:nGNXb9z4Fs

Further company coverage: PYXS.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.